(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Bolsonaro discharged from hospital and placed under house arrest - 2Space debris: will it take a catastrophe for nations to take the issue seriously?
- 36 Travel Services for Colorful Get-aways: Pick Your Fantasy Escape
- 4This ‘CSI: Miami’ star spent years solving crimes on TV. Then she became the target of one herself.
- 5Closets for Your Room: Plan and Utility Features
- Hoist Your Style: Famous Hairdos for Ladies
- Find Your Internal Culinary expert: Cooking Strategies and Recipes
- Washington state experiences historic flooding as Skagit River hits record high level. See flooding maps, highway closures and forecasts.
- Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
- Turning to turkey’s tryptophan to boost mood? Not so fast
- Jupiter and the moon take a sunset stroll on March 26. Here's how to see it
- Brazil's agricultural research agency gets cannabis research greenlight
- Canada cancels its 1st moon rover: 'It's hopefully not a lost cause'
- Figure out How to Pick a SUV with Senior-Accommodating Tech Elements
